674367-99-8

Basic information

• Product Name: 1H-[1,2,4]Triazolo[1,2-a]pyridazine-1,3(2H)-dione, 5-[5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-6-yl]-5,8 -dihydro-7-methyl-2-phenyl-
• CAS NO: 674367-99-8
• Molecular Formula: C31H27N3O7
• Molecular Weight: 553.571
• Mol File: 674367-99-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1H-[1,2,4]Triazolo[1,2-a]pyridazine-1,3(2H)-dione, 5-[5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-6-yl]-5,8 -dihydro-7-methyl-2-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-[1,2,4]Triazolo[1,2-a]pyridazine-1,3(2H)-dione, 5-[5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-6-yl]-5,8 -dihydro-7-methyl-2-phenyl-(674367-99-8)
• EPA Substance Registry System: 1H-[1,2,4]Triazolo[1,2-a]pyridazine-1,3(2H)-dione, 5-[5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-6-yl]-5,8 -dihydro-7-methyl-2-phenyl-(674367-99-8)

Safety Data

• Hazardous Substances Data: 674367-99-8(Hazardous Substances Data)

Upstream product

• 78-80-8 2-methylbut-1-en-3-yne 
• 100-07-2 4-methoxy-benzoyl chloride 
• 76288-41-0 1-(4'-methoxyphenyl)-3-(2''-hydroxy-3'',6''-dimethoxyphenyl)-1,3-propanedione 
• 83171-42-0 4,6-dimethoxy-2-(4'-methoxybenzoyloxy)acetophenone 
• 5631-70-9 4',5,7-trimethoxyflavone 
• 5128-44-9 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one 
• 50848-66-3 7,4'-dimethoxy-5-hydroxy-6-iodoflavone 
• 90-24-4 2-hydroxy-4,6-dimethoxyacetophenone 
• 115010-71-4 (E)-2-(3-Methylbuta-1,3-dien-1-yl)benzo[1,3,2]dioxaborole 
• 4233-33-4 4-Phenyl-1,2,4-triazolidine-3,5-dione 
• 674367-92-1 5,7-Dimethoxy-2-(4-methoxy-phenyl)-6-((E)-3-methyl-buta-1,3-dienyl)-chromen-4-one 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR POTENTIATING ANTIBIOTIC ACTIVITY

[205] The present invention provides compounds that potentiate the activity of antibiotic agents, particularly quinolones such as norflaxin. The invention further provides compositions, e.g., pharmaceutical compositions, comprising the inventive compounds. The invention also provides compositions comprising an antibiotic (e.g., a quinolone) and a compound that potentiates activity of the antibiotic. The invention further provides methods of treating a subject comprising administering any of the inventive compounds or compositions to the subject. The invention also provides screening methods to identify compounds that potentiate the activity of an antibiotic, e.g., a quinolone.